227 related articles for article (PubMed ID: 16518351)
1. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
Suissa S; Hutchinson T; Brophy JM; Kezouh A
Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitor use and the long-term risk of renal failure in diabetics.
Woo KT; Lau YK; Wong KS; Chan CM
Kidney Int; 2006 Oct; 70(7):1376-7; author reply 1378. PubMed ID: 16988741
[No Abstract] [Full Text] [Related]
4. ACE inhibitor use and the increased long-term risk of renal failure in diabetes.
Hamming I; Goor Hv; Navis GJ
Kidney Int; 2006 Oct; 70(7):1377-8; author reply 1378. PubMed ID: 16988743
[No Abstract] [Full Text] [Related]
5. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
6. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
8. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Bakris GL; Toto RD; McCullough PA
J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
[TBL] [Abstract][Full Text] [Related]
10. [Renal complications of diabetes].
Tielemans C
Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
[TBL] [Abstract][Full Text] [Related]
11. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
Boner G; Cao Z; Cooper ME
Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
[TBL] [Abstract][Full Text] [Related]
12. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
Sawicki PT
Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
[TBL] [Abstract][Full Text] [Related]
13. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
Schnack C; Schernthaner G
Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive therapy in diabetes mellitus].
Hess B
Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
Sica DA; Gehr TW; Fernandez A
Drug Saf; 2000 May; 22(5):350-60. PubMed ID: 10830252
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and renal failure in diabetes.
Hiremath S; Zimmerman D; Knoll GA
Kidney Int; 2006 Oct; 70(7):1377; author reply 1378. PubMed ID: 16988744
[No Abstract] [Full Text] [Related]
18. Calcium channel blockers in the prevention of end stage renal disease: a review.
Derwa A; Peeters P; Vanholder R
Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes.
Sobolewski BA; Zgibor JC; Orchard TJ
Diabetes Res Clin Pract; 2004 Jul; 65(1):37-43. PubMed ID: 15163476
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
